The most expensive drugs in the US
From Orchard’s Lenmeldy to Vertex and CRISPR Therapeutics’s Casgevy, Pharmaceutical Technology lists the top ten priciest therapies in the US.
Cell & Gene Therapy
Gene therapy: How Veristat cut trial database costs by 30%
APAC leaps ahead in adoptive cell therapy space
Anti-obesity drugs will be 2024’s defining trend
FDA grants RMAT designation to Taysha’s Rett syndrome gene therapy
Cell and gene therapy companies trip at scalability hurdle
Q&A: Cell and gene therapy value assessments need a rework to allow access
Pluri launches manufacturing division as cell therapy pipeline progresses
